Technology News and Research

RSS

Study results of new PCR technology that reports mutations associated with FXS announced

Asuragen, Inc. announced today the results of a collaborative study with scientists at the M.I.N.D. Institute at the University of California Davis evaluating a new PCR technology that reproducibly reports mutations associated with Fragile X syndrome (FXS).

2 Mar 2010

Oberthur Technologies supplies doctors and first responders with FIPS 201 PIV cards

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of smart credentials to the U.S. Federal government, is supplying doctors and first responders with FIPS 201 compliant, physical and logical access Personal Identify Verification (PIV) cards to assist in response to disaster.

2 Mar 2010

Agilent Technologies announces new lab informatics suite at Pittcon 2010

Agilent’s major new lab informatics suite, the OpenLAB portfolio, is designed to enable customers to easily capture, analyze and share scientific data throughout the lab and across the enterprise. OpenLAB is scalable, open architecture based on industry open standards.

2 Mar 2010

BioSante Pharmaceuticals announces receipt of two US patents directed to 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced the receipt of two US patents directed to its 2A/Furin technology for expressing proteins. The first issued US patent, US Pat. No., 7,632,059, covers methods for manufacturing recombinant antibodies.

2 Mar 2010

AdMeTech Foundation: Health care reform highlights need for better screening and prevention of prostate cancer

AdMeTech Foundation announced today that its President and CEO Dr. Faina Shtern will testify on March 4 before the U.S. House Committee on Oversight and Government Reform on how health care reform highlights the need for increased funding for research aimed at creating accurate, life-saving diagnostic tools for prostate cancer, which will improve screening, prevention, early detection and reduce health costs.

2 Mar 2010

febit releases updated Geniom Biochip containing 58 new miRNA sequences

febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been validated using the ABI TaqMan miRNA qRT-PCR assay and are now available for further studies using febit's microarray technology for miRNA-profiling.

2 Mar 2010

Columbia University, FairChoice Systems sign agreement to market student health information system

Columbia University and FairChoice Systems, Inc. have signed a multi-year commercialization agreement that will bring to market a cost-effective, online student health information system developed and implemented by Columbia University's own Student Health Services.

2 Mar 2010

Hill-Rom extends smart room technology for improved clinical workflow

Today, Hill-Rom announced the extension of its smart room technology to provide a choice of solutions that connect the smart bed and other medical devices to the Electronic Medical Record (EMR) on both a wired and a wireless platform.

2 Mar 2010

GTC Biotherapeutics achieves high-level production of TG20 monoclonal antibody

GTC Biotherapeutics, Inc. announced that it has achieved high-level production of TG20; an anti-CD20 monoclonal antibody (MAb). The TG20 MAb, which is produced in the milk of transgenic goats, is being co-developed by GTC and LFB as part of the LFB-GTC joint venture.

2 Mar 2010

HMS initiates new interoperability product for customers

Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.

2 Mar 2010

BIO-key International to display fingerprint biometric solutions At RSA Conference 2010

BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today announced that its fingerprint biometric solutions will be on display at the RSA Conference 2010, in the Initiative for Open AuTHentication (OATH) Pavilion, booth # 2023.

2 Mar 2010

Merge Healthcare launches Patient Kiosk and deploys new patient engagement tool in U.S. imaging centers

In an effort to leverage health information exchange technology for consumers, Merge Healthcare today announced the introduction of the Merge Patient Kiosk™ and the successful deployment of this new patient engagement tool in several imaging centers in the U.S. Combining the best of kiosk technologies already present in other industries and the specific requirements of healthcare consumers, the Merge solution creates a new way for imaging practices to stay connected to their customers.

2 Mar 2010

Life Technologies announces early stage results from SMS technology

Life Technologies Corporation today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

2 Mar 2010

NovoStent receives CE Mark for SAMBA Stent and Delivery System for treatment of PAD

NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of strength, flexibility and vessel coverage.

2 Mar 2010

Getting pregnant the "traditional" way or by assisted reproduction does not affect birthing process or the baby

Whether a women gets pregnant the "traditional" way or by assisted reproduction has no effect on the birthing process itself or the baby, researchers at the Norwegian University of Science and Technology (NTNU) have found.

2 Mar 2010

Researchers proceed to develop vaccination to reverse neurological damage seen with Parkinson's disease

Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.

2 Mar 2010

AnaptysBio announces strategic collaboration to generate novel antibodies for specified disease target

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a strategic collaboration with an undisclosed leading global pharmaceutical company to generate novel antibody therapeutics to a specified disease target. This is the third collaboration with a leading pharmaceutical company announced by AnaptysBio during 2010.

1 Mar 2010

Aventyn launches healthKrypt security technology for health information and trusted transaction processing

Aventyn Inc., an innovative provider of secure connected clinical information processing solutions, today announced the introduction of healthKrypt™, patent pending technology for securing health information and trusted transaction processing. This announcement was made jointly at HIMMS in Atlanta, GA and RSA2010 in San Francisco, CA.

1 Mar 2010

Olympus America signs nonexclusive worldwide licensing agreement with Omnyx

Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with Omnyx, LLC, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, allowing Omnyx to access an extensive portfolio of Olympus America patents in the field of virtual microscopy and digital pathology, to help develop solutions in the digital pathology field.

From Evident Corporation - Life Sciences 1 Mar 2010

MiMedx Group's HydroFix Spine Shield device receives CE Mark

MiMedx Group, Inc. announced today that the Company received the CE Mark for its HydroFix™ Spine Shield device and was certified for design, development, and production of post-surgical adhesion inhibiting barriers.

1 Mar 2010

Technology News and Research

Study results of new PCR technology that reports mutations associated with FXS announced

Oberthur Technologies supplies doctors and first responders with FIPS 201 PIV cards

Agilent Technologies announces new lab informatics suite at Pittcon 2010

BioSante Pharmaceuticals announces receipt of two US patents directed to 2A/Furin technology

AdMeTech Foundation: Health care reform highlights need for better screening and prevention of prostate cancer

febit releases updated Geniom Biochip containing 58 new miRNA sequences

Columbia University, FairChoice Systems sign agreement to market student health information system

Hill-Rom extends smart room technology for improved clinical workflow

GTC Biotherapeutics achieves high-level production of TG20 monoclonal antibody

HMS initiates new interoperability product for customers

BIO-key International to display fingerprint biometric solutions At RSA Conference 2010

Merge Healthcare launches Patient Kiosk and deploys new patient engagement tool in U.S. imaging centers

Life Technologies announces early stage results from SMS technology

NovoStent receives CE Mark for SAMBA Stent and Delivery System for treatment of PAD

Getting pregnant the "traditional" way or by assisted reproduction does not affect birthing process or the baby

Researchers proceed to develop vaccination to reverse neurological damage seen with Parkinson's disease

AnaptysBio announces strategic collaboration to generate novel antibodies for specified disease target

Aventyn launches healthKrypt security technology for health information and trusted transaction processing

Olympus America signs nonexclusive worldwide licensing agreement with Omnyx

MiMedx Group's HydroFix Spine Shield device receives CE Mark

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News